💾 Data Updated: 2025 HTS Revision 30 • Last updated: November 24, 2025

3002.90.52.10 - Whole human blood

Details

FieldValue
Unit of Quantitykg
General Rate of DutyFree
Special Rate of DutyN/A
Column 2 Rate of DutyFree
Quota QuantityN/A
Additional DutiesN/A

Overview

This HTS classification, 3002.90.52.10, specifically covers whole human blood when intended for therapeutic, prophylactic, or diagnostic purposes. This includes blood collected from human donors for transfusion, medical treatment, or laboratory testing. The primary characteristic is its intact cellular composition and fluid matrix, originating from humans.

It is important to distinguish this category from its siblings. While 3002.90.52.20 covers antiallergenic preparations, which are typically derived products or synthetic substances designed to treat allergic reactions, this code is for the unprocessed biological material itself. Furthermore, 3002.90.52.50 encompasses "other" immunological products not specifically enumerated, making whole human blood a distinct, primary biological product within this group.

As this is a leaf node in the HTS classification, there are no further subcategories under 3002.90.52.10. Therefore, classification under this code relies on confirming the product is indeed whole human blood and that its intended use aligns with medical or diagnostic applications, as outlined by the broader scope of heading 3002.

Stay Updated

Join our newsletter to get all updates of the harmonized Tariff Schedule.